Vice President - Foster City, United States - Gilead Sciences

Gilead Sciences

Verified Company

Foster City, United States

3 weeks ago

Posted by:

Mark Lane

beBee recruiter

Description

For Current Gilead Employees and Contractors:
Please log onto your

Internal Career Site

At Gilead, we're creating a healthier world for all people.

For more than 35 years, we've tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer - working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe.

We continue to fight against the world's biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.

Every member of Gilead's team plays a critical role in the discovery and development of life-changing scientific innovations.

Our employees are our greatest asset as we work to achieve our bold ambitions, and we're looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite.

As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations.

Join Gilead and help create possible, together.

Job Description:

Gilead Sciences, Inc.

is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.

The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer.

Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more than 30 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention, testing and linkage to care, and cure research.

Today, millions of people living with HIV globally receive antiretroviral therapy provided by Gilead or one of the company's manufacturing partners.

We are leading the charge to end the epidemic for everyone, everywhere, from the first single tablet regimen to treat HIV, to medicines that help prevent it, to our continued search for a cure.

We have helped cure millions of people with hepatitis C.

As we work to eliminate it by 2030, we are also providing options for people with hepatitis B and D.

We delivered the first approved treatment for COVID-19, now available in 170+ countries. Our research and preparation for future public health crises is ongoing.

We are advancing an early pipeline of potentially best-in-class molecules to control chronic inflammatory and fibrotic diseases.

And, we are on our way to becoming a top 10 oncology company by 2030 and eventually curing certain cancers through cell therapy.

Together with Kite, we have built a world-class oncology portfolio with nearly 50 clinical-stage programs across nearly every tumor type.

Since its founding in Foster City, California, in 1987, Gilead has become a leading biopharmaceutical company with a rapidly expanding product portfolio, a growing pipeline of investigational drugs and 18,000+ employees in offices across six continents.

Millions of people around the world are living healthier lives because of innovative therapies developed by Gilead.

Today, our innovative approach to external partnerships, and our internal research and development effort includes hundreds of ongoing and planned clinical studies evaluating compounds with the potential to become the next generation of effective medicines.

Vice President & Head of Global Medical Affairs - Virology and Liver, Inflammation, Fibrosis, & Established Products

The Vice President, Global Medical Affairs (GMA) will provide oversight in the areas of prevention (PrEP) and treatment of HIV, hepatitis (B, C, and Delta), inflammation and fibrosis, as well as established products across Gilead's therapeutic areas.

The VP, GMA will have overall responsibility for overseeing the Medical Affairs Department globally in these therapeutic areas by providing strategic leadership for all Medical Affairs activities and developing and executing the Integrated Strategic Plan (ISP).

Will oversee the development and execution of the long-term strategy through the global Medical Affairs Plan of Action (POA) for each of these therapeutic areas based on a landscape assessment of unmet needs, with inputs from colleagues within Medical Affairs as well as cross-functionally, and provide oversight and direction to country affiliate Medical Affairs teams for local implementation.

Additionally, will oversee the Medical Affairs Research group, which provides global operational MA research capabilities across therapeutic areas.

The VP, GMA will report to the SVP and Head of Global Medical Affairs. They will operate cross-functionally by engaging with the diverse teams across Gilead including, but not limited to: Research and Development, Regulatory Affairs, Commerc